VKH
SLS icon

Virtu KCG Holdings’s SELLAS Life Sciences SLS Stock Holding History

Virtu KCG Holdings’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$130K Buy
149
+130
+684% +$113K ﹤0.01% 2343
2017
Q1 		$18K Sell
19
-21
-53% -$34.8K ﹤0.01% 2984
2016
Q4 		$117K Buy
+40
New +$233K ﹤0.01% 2856

Other funds holding SLS

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return

Virtu KCG Holdings's SLS Position: Q2 2017 in Review

Virtu KCG Holdings increased its SELLAS Life Sciences (SLS) stake by 684% in Q2 2017, buying an estimated $113K and bringing the position to 149 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #2343.

Virtu KCG Holdings first reported a position in SLS in Q4 2016 and has held it in 3 quarters since. 34 funds tracked by Wall St. Rank hold SLS as of Q2 2017.

  • Virtu KCG Holdings held 149 shares of SELLAS Life Sciences worth $130K as of Q2 2017.
  • Virtu KCG Holdings bought 130 SELLAS Life Sciences shares in Q2 2017, an estimated $113K.
  • SELLAS Life Sciences made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2343 holding.
  • Virtu KCG Holdings first reported a position in SELLAS Life Sciences in Q4 2016 and has held it in 3 quarters since.
  • 34 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.